Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population

Y. Matsubara, T. Hayakawa, T. Tsuda, E. Takeshita, G. Watanabe, Mitsuru Murata, K. Watanabe, Y. Ikeda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Plasminogen activator inhibitor-1 (PAI-1) has a central role in the regulation of the fibrinolytic enzyme system. An elevated plasma PAI-1 level is associated with thrombotic disorders. In vitro and in vivo studies indicate that the renin-angiotensin system is involved in the regulation of PAI-1. A 287-bp insertion/deletion (I/D) polymorphism in the gene-encoding angiotensin converting enzyme (ACE) is associated with cardiovascular disorders. We evaluated the association between the ACE I/D polymorphism and plasma PAI-1 antigen levels in 110 healthy Japanese male subjects. Subjects with the D-allele of the gene-encoding ACE had higher levels of PAI-1 (26.3 ± 14.7 ng/ml, mean ± standard deviation) compared with those without (21.0 ± 12.0; P = 0.0491). A multiple linear regression model with independent variables (age, body-mass index, total cholesterol level, triglyceride level, ACE I/D genotype, and PAI-1 genotype due to a single guanine I/D polymorphism in the PAI-1 gene) demonstrated that the triglyceride level (P = 0.0059) and ACE I/D genotype (P = 0.0372) were independent predictors of plasma PAI-1 antigen levels in a subset of the subjects without diabetes mellitus that were not taking lipid-lowering drugs. These findings suggest that the ACE I/D polymorphism is a genetic factor for the regulation of plasma PAI-1 antigen levels in the healthy Japanese population. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish
Pages (from-to)115-120
Number of pages6
JournalBlood Coagulation and Fibrinolysis
Volume11
Issue number2
Publication statusPublished - 2000

Fingerprint

Plasminogen Activator Inhibitor 1
Peptidyl-Dipeptidase A
Antigens
Population
Genotype
Linear Models
Triglycerides
Genes
Guanine
Renin-Angiotensin System
Diabetes Mellitus
Body Mass Index
Alleles
Cholesterol
Lipids
Enzymes

Keywords

  • Angiotensin converting enzyme
  • Genetics
  • Plasminogen activator inhibitor-1
  • Polymorphism
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Hematology

Cite this

Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population. / Matsubara, Y.; Hayakawa, T.; Tsuda, T.; Takeshita, E.; Watanabe, G.; Murata, Mitsuru; Watanabe, K.; Ikeda, Y.

In: Blood Coagulation and Fibrinolysis, Vol. 11, No. 2, 2000, p. 115-120.

Research output: Contribution to journalArticle

@article{d6a5910814704e5e95659a1e20d40fad,
title = "Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population",
abstract = "Plasminogen activator inhibitor-1 (PAI-1) has a central role in the regulation of the fibrinolytic enzyme system. An elevated plasma PAI-1 level is associated with thrombotic disorders. In vitro and in vivo studies indicate that the renin-angiotensin system is involved in the regulation of PAI-1. A 287-bp insertion/deletion (I/D) polymorphism in the gene-encoding angiotensin converting enzyme (ACE) is associated with cardiovascular disorders. We evaluated the association between the ACE I/D polymorphism and plasma PAI-1 antigen levels in 110 healthy Japanese male subjects. Subjects with the D-allele of the gene-encoding ACE had higher levels of PAI-1 (26.3 ± 14.7 ng/ml, mean ± standard deviation) compared with those without (21.0 ± 12.0; P = 0.0491). A multiple linear regression model with independent variables (age, body-mass index, total cholesterol level, triglyceride level, ACE I/D genotype, and PAI-1 genotype due to a single guanine I/D polymorphism in the PAI-1 gene) demonstrated that the triglyceride level (P = 0.0059) and ACE I/D genotype (P = 0.0372) were independent predictors of plasma PAI-1 antigen levels in a subset of the subjects without diabetes mellitus that were not taking lipid-lowering drugs. These findings suggest that the ACE I/D polymorphism is a genetic factor for the regulation of plasma PAI-1 antigen levels in the healthy Japanese population. (C) 2000 Lippincott Williams and Wilkins.",
keywords = "Angiotensin converting enzyme, Genetics, Plasminogen activator inhibitor-1, Polymorphism, Renin-angiotensin system",
author = "Y. Matsubara and T. Hayakawa and T. Tsuda and E. Takeshita and G. Watanabe and Mitsuru Murata and K. Watanabe and Y. Ikeda",
year = "2000",
language = "English",
volume = "11",
pages = "115--120",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population

AU - Matsubara, Y.

AU - Hayakawa, T.

AU - Tsuda, T.

AU - Takeshita, E.

AU - Watanabe, G.

AU - Murata, Mitsuru

AU - Watanabe, K.

AU - Ikeda, Y.

PY - 2000

Y1 - 2000

N2 - Plasminogen activator inhibitor-1 (PAI-1) has a central role in the regulation of the fibrinolytic enzyme system. An elevated plasma PAI-1 level is associated with thrombotic disorders. In vitro and in vivo studies indicate that the renin-angiotensin system is involved in the regulation of PAI-1. A 287-bp insertion/deletion (I/D) polymorphism in the gene-encoding angiotensin converting enzyme (ACE) is associated with cardiovascular disorders. We evaluated the association between the ACE I/D polymorphism and plasma PAI-1 antigen levels in 110 healthy Japanese male subjects. Subjects with the D-allele of the gene-encoding ACE had higher levels of PAI-1 (26.3 ± 14.7 ng/ml, mean ± standard deviation) compared with those without (21.0 ± 12.0; P = 0.0491). A multiple linear regression model with independent variables (age, body-mass index, total cholesterol level, triglyceride level, ACE I/D genotype, and PAI-1 genotype due to a single guanine I/D polymorphism in the PAI-1 gene) demonstrated that the triglyceride level (P = 0.0059) and ACE I/D genotype (P = 0.0372) were independent predictors of plasma PAI-1 antigen levels in a subset of the subjects without diabetes mellitus that were not taking lipid-lowering drugs. These findings suggest that the ACE I/D polymorphism is a genetic factor for the regulation of plasma PAI-1 antigen levels in the healthy Japanese population. (C) 2000 Lippincott Williams and Wilkins.

AB - Plasminogen activator inhibitor-1 (PAI-1) has a central role in the regulation of the fibrinolytic enzyme system. An elevated plasma PAI-1 level is associated with thrombotic disorders. In vitro and in vivo studies indicate that the renin-angiotensin system is involved in the regulation of PAI-1. A 287-bp insertion/deletion (I/D) polymorphism in the gene-encoding angiotensin converting enzyme (ACE) is associated with cardiovascular disorders. We evaluated the association between the ACE I/D polymorphism and plasma PAI-1 antigen levels in 110 healthy Japanese male subjects. Subjects with the D-allele of the gene-encoding ACE had higher levels of PAI-1 (26.3 ± 14.7 ng/ml, mean ± standard deviation) compared with those without (21.0 ± 12.0; P = 0.0491). A multiple linear regression model with independent variables (age, body-mass index, total cholesterol level, triglyceride level, ACE I/D genotype, and PAI-1 genotype due to a single guanine I/D polymorphism in the PAI-1 gene) demonstrated that the triglyceride level (P = 0.0059) and ACE I/D genotype (P = 0.0372) were independent predictors of plasma PAI-1 antigen levels in a subset of the subjects without diabetes mellitus that were not taking lipid-lowering drugs. These findings suggest that the ACE I/D polymorphism is a genetic factor for the regulation of plasma PAI-1 antigen levels in the healthy Japanese population. (C) 2000 Lippincott Williams and Wilkins.

KW - Angiotensin converting enzyme

KW - Genetics

KW - Plasminogen activator inhibitor-1

KW - Polymorphism

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=0033999246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033999246&partnerID=8YFLogxK

M3 - Article

C2 - 10759003

AN - SCOPUS:0033999246

VL - 11

SP - 115

EP - 120

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 2

ER -